Basic Aczone Information

• INN (International Nonproprietary Name): Dapsone (also known as 4,4’-diaminodiphenylsulfone; CAS: 80-08-0).
• Brand Names Available In Canada (English): Aczone® is the primary brand name noted in the product information and is marketed internationally, including Canada, primarily as a 7.5% gel in 60 g and 90 g tubes; generic dapsone topical gel is listed internationally but generic suppliers specific to Canada are not specified.
• ATC Code: D10AX05 (Other Anti-Acne Preparations For Topical Use).
• Forms & Dosages: Topical gel formulations at 5% and 7.5% strengths supplied in tubes and multi-use dispensers; 5% is labelled for ages ≥12 years (once or twice daily) and 7.5% for ages ≥9 years (once daily); typical treatment review at up to 12 weeks.
• Manufacturers In Canada (English): Reference product holder listed as Allergan, Inc. (global supplier); multiple generic manufacturers exist internationally (Teva, Alkem, Amneal, etc.); a dedicated Canadian manufacturer is not specified in the product data.
• Registration Status In Canada (English): The product is listed as marketed in Canada in the product information and is prescription-only (Rx-only) in jurisdictions found; confirm current Canadian registration and DIN via the Health Canada Drug Product Database for the most up-to-date status.
• OTC / Rx Classification: Prescription Only (Rx-Only).

Major National Pharmacy Chains (Shoppers Drug Mart, Rexall, London Drugs)

Canadians ask where they can pick up Aczone or dapsone gel and whether it will be in stock locally.

Major national chains such as Shoppers Drug Mart, Rexall and London Drugs commonly dispense Aczone by prescription.

Stock and formulary listings vary by store and by province, so availability is not uniform across locations.

Pharmacies will often order 60 g or 90 g tubes on request if not held on the shelf.

Generics may be carried sporadically, depending on supplier contracts and provincial formulary decisions.

• Shoppers Drug Mart: Stocked in many stores but availability varies by province and store; can order on prescription.
• Rexall: Frequently able to source Aczone or equivalent dapsone gel by request; check local store for stock.
• London Drugs: Serves Western Canada with variable stocking; can order tubes if needed.

In‑store dispensing often allows same‑day pickup when the product is on the shelf or next‑day if ordered from the chain distribution centre.

Online pharmacy ordering from certified Canadian e‑pharmacies may offer delivery and prescription processing options that complement in‑store access.

Online Pharmacy Trends In Canada (Including Provincial Restrictions)

Telederm and e‑pharmacy services have grown, making it easier to get a dermatology prescription and home delivery for topical dapsone gel.

Provincial rules limit cross‑province dispensing for reimbursement and sometimes for shipping, so many pharmacies require a local prescriber for provincial drug plan claims.

Some online Canadian pharmacies provide national shipping but will request a valid prescription and may verify prescriber location for provincial coverage.

Cross‑border purchases from U.S. or international sites happen, but they carry the risk of non‑DIN products and potential customs delays or refusal.

For coverage under provincial drug plans such as Ontario Drug Benefit, BC PharmaCare or RAMQ, a product must have the appropriate Canadian licence and DIN; otherwise the cost is out of pocket.

In our online pharmacy, aczone is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Price Ranges By Package Size (With Provincial Differences)

Expect price variation between brand Aczone and any generic dapsone gel that may be offered by individual stores or e‑pharmacies.

Brand Aczone (7.5% in 60 g or 90 g tubes) typically commands a premium over generics where generics are available.

Provincial drug plans may cover Aczone only when a DIN is listed and when prescribing meets plan criteria.

These ranges are illustrative and prices change with supplier contracts and provincial formularies.

Canadian Patient Insights & Satisfaction Levels

Where do Canadian patients report their experience and what do they say about results and access?

Forum And Review Platforms (Reddit Canada, HealthBoards, AskDocs)

Discussions about Aczone and dapsone gel appear on platforms such as Reddit Canada, HealthBoards and AskDocs.

Patients use these forums to share timelines, side effects and tips for sourcing the product in Canada.

Common conversation points include prescription wait times, provincial reimbursement hurdles and difficulty finding the 7.5% formulation locally.

Reported Benefits And Challenges From Canadian Patients

Overall patient sentiment is pragmatic: many report fewer inflammatory pustules and improved redness over weeks.

Some users report noticeable improvement within a few weeks, with maximum benefit often described at three months.

Common challenges include local irritation, transient dryness and occasional difficulty sourcing the preferred strength.

Patients often compare in‑store brand Aczone costs with US or online generics and ask pharmacists about G6PD testing history before use.

• Pros: Effective for inflammatory acne, useful where antibiotics are undesirable, generally well tolerated.
• Cons: Local irritation, cost concerns for brand product, potential staining with benzoyl peroxide combinations.

Product Overview & Brand Variants

What exactly is inside the tube and how is it classified?

INN And Brand Names Used In Canada

The INN is dapsone, also listed as 4,4’-diaminodiphenylsulfone (CAS: 80-08-0).

The primary brand noted internationally is Aczone® distributed by Allergan, Inc.

Formulations exist at 5% and 7.5% topical gel strengths and are supplied in tubes and multi‑use dispensers.

Legal Classification Under Health Canada

Dapsone topical gel is classified as a prescription‑only product in the jurisdictions found in the product information.

Pharmacies in Canada must verify the product licence and DIN through Health Canada for reimbursement and listing purposes.

INN

Dapsone (4,4’-diaminodiphenylsulfone; CAS: 80-08-0).

Brand

Aczone® (Allergan, Inc.).

Strengths

5% and 7.5% topical gel.

Packaging

60 g and 90 g tubes or multi‑use dispensers.

ATC Code

D10AX05.

Pharmacists should ensure prescriptions specify strength and tube size to avoid unintended substitutions.

Indications In Local Canadian Medical Practice

When do Canadian prescribers choose topical dapsone and are there off‑label uses to know about?

Approved Uses (Health Canada DIN Context)

Topical dapsone gel is indicated for inflammatory acne vulgaris per product information and common prescribing practice.

Because it is prescription-only, dermatologists and family physicians usually reserve it for inflammatory lesions or when other topicals are not tolerated.

Off-Label Patterns In Canadian Healthcare

Clinicians sometimes use topical dapsone for focal inflammatory rosacea‑type lesions or for acne where topical antibiotics are not suitable.

Pediatric use follows label age limits with 5% generally for ages 12 and up and 7.5% for ages 9 and up, with clinicians documenting informed consent for younger patients.

Always confirm DIN and provincial coverage before prescribing for reimbursement purposes.

How It Works In The Body

Patients often ask whether aczone is an antibiotic or an anti‑inflammatory.

Layman’s Explanation (Canadian Patient‑Friendly Tone)

Dapsone topical gel calms the inflammation in pimples and pustules rather than acting like a traditional antibiotic cream.

Applied as a thin layer to affected areas, it helps reduce redness and the number of inflammatory lesions over weeks.

Initial improvement is often seen within weeks, with full benefits sometimes requiring up to three months of consistent use.

Clinical Detail From Health Canada Resources

Pharmacologically, topical dapsone is classified under ATC D10AX05 and has anti‑inflammatory activity with minimal systemic absorption through intact skin.

Systemic exposure is limited but not zero, so rare systemic adverse events such as methemoglobinemia or haemolytic anaemia have been reported in the literature and product information.

Health Canada product monographs and the Drug Product Database provide official pharmacodynamics and pharmacokinetics details and should be consulted for specific prescribing information.

Dosage & Administration

How should patients apply the gel and what dose fits which age group?

Standard Regimens Per Canadian Guidelines

Follow the product monograph dosing: 5% gel for patients aged 12 years and older, applied once or twice daily depending on label instructions.

7.5% gel is labelled for patients aged 9 years and older and is applied once daily.

Apply a pea‑sized amount to the entire face or affected area on clean, dry skin, and rub in gently and completely.

Reassess therapy if there is no improvement after 12 weeks.

Adjustments By Patient Type (With Canadian Clinical Notes)

No formal dose reductions are specified for elderly patients, but monitor for local irritation.

Liver and kidney impairment dosing adjustments are not established due to minimal systemic absorption; exercise clinical caution as appropriate.

For missed doses, apply as soon as remembered unless the next dose is near; do not double up.

• Patient Counselling Checklist: confirm age and strength, demonstrate pea‑sized application, advise on expected timeline and when to return for review.

Contraindications & Side Effects

Who should avoid dapsone gel and what adverse effects should patients watch for?

Common (Health Canada‑Approved List)

Absolute contraindications include known hypersensitivity to dapsone, sulfone antibiotics, or any excipient in the formulation.

Severe anemia and certain enzyme deficiencies such as G6PD deficiency are contraindications due to haemolysis risk.

Common local side effects are dryness, redness, burning, stinging, itching and mild rash, which are usually transient.

Rare But Serious (With Canadian Pharmacovigilance Data)

Rare but serious reactions include methemoglobinemia and haemolytic anaemia, primarily described with systemic dapsone but possible with topical use in predisposed individuals.

Canadian pharmacovigilance reports for topical dapsone are limited but do include rare hematologic adverse events; report adverse events to Health Canada through the Canada Vigilance Program.

• Pharmacist Action Steps: counsel patients on symptoms of severe reactions, advise discontinuation and urgent assessment for shortness of breath, cyanosis or dark urine, and report to provincial poison centre and Health Canada as needed.

Comparable Medicines In Canada

What other topical options might a pharmacist suggest and how do they compare to dapsone?

Alternatives Table (With DIN References)

Pros And Cons List

Dapsone Advantage: anti‑inflammatory action with low selection pressure for antibiotic resistance.

Dapsone Downsides: potential local irritation, higher cost for branded Aczone, and prescription requirement.

Benzoyl Peroxide Pros: widely available OTC and effective antibacterial action.

Benzoyl Peroxide Cons: skin drying and local irritation; can temporarily cause yellow/orange staining when combined with dapsone.

Retinoid Pros: effective for comedonal acne and long‑term maintenance.

Retinoid Cons: photosensitivity and specific contraindications in pregnancy.

Current Research & Trends

What is new in the evidence base for topical dapsone from 2022 to 2025?

Recent trials have compared 7.5% once‑daily regimens with 5% twice‑daily formulations and found similar efficacy with the 7.5% strength offering convenience for adherence.

Research focuses on antibiotic‑sparing acne strategies and on subgroups such as adult female acne where anti‑inflammatory topical agents are useful.

Conference abstracts from Canadian dermatology meetings highlight real‑world tolerability, adherence patterns and cost‑effectiveness comparisons with retinoid and benzoyl peroxide regimens.

Ongoing pharmacovigilance work continues to monitor rare hematologic events and interactions with oxidizing agents such as benzoyl peroxide.

Common Patient Questions In Canada

Patients frequently ask a set of practical questions when aczone is prescribed or considered.

1. Do I need a prescription?
2. Yes — product information and national regulatory listings indicate prescription‑only status; however, some online services may offer different dispensing pathways.
3. Will my provincial plan cover it?
4. Coverage depends on whether the product has a Canadian DIN and whether it is listed on the provincial formulary; check Ontario Drug Benefit, BC PharmaCare, or RAMQ rules for specifics.
5. Which strength should I choose?
6. 7.5% once daily is convenient; 5% may be used once or twice daily depending on age and clinician preference.
7. Can I use it with benzoyl peroxide or retinoids?
8. Yes with clinician guidance, but benzoyl peroxide may cause temporary yellow/orange skin discoloration when combined with dapsone.
9. Are safety tests needed?
10. Baseline lab testing is not routinely required for topical use unless there is known G6PD deficiency or history of methemoglobinemia; otherwise monitor clinically for symptoms.

Regulatory Status

How does Health Canada regulate Aczone and why does the DIN matter?

Health Canada Approval Process

Prescription drugs in Canada require a Notice of Compliance and a Drug Identification Number (DIN) to be marketed and reimbursed.

Pharmacies and prescribers should verify Health Canada’s Drug Product Database for the current licence status and DIN before relying on provincial reimbursement.

DIN Number Relevance

The DIN determines how pharmacies list the product and whether provincial formularies will reimburse the cost to eligible patients.

Adverse events are reported through the Canada Vigilance Program to support national pharmacovigilance.

• Step Checklist: verify DIN in the Health Canada database, check provincial formulary status, document prescribing rationale and patient counselling, and report adverse events if necessary.

Visual Recommendations

What images and graphics help patients understand proper use and build trust on product pages?

Recommended visuals include a quick reference dosing infographic showing 5% vs 7.5% age and frequency guidance.

Include a “How To Apply” step graphic with a pea‑sized amount illustration and a face map highlighting common application areas.

Create a storage and transport icon panel advising storage up to 25°C and warning against freezing or leaving in a hot car in summer or an unheated vehicle in winter.

A compact timeline visual helps set expectations: initial improvement in weeks and full effect up to three months.

Buying & Storage Advice

Where should Canadians buy aczone and how should it be kept at home?

In-Store Vs. Online Canadian Purchase Tips

For reliability, purchase from licensed Canadian pharmacies such as Shoppers Drug Mart, Rexall or London Drugs, or from certified Canadian e‑pharmacies.

Compare in‑store and online prices and check the product has a Canadian DIN if reimbursement is intended.

Cross‑border purchases may be cheaper but can include non‑DIN formulations and customs delays or refusal.

Proper Storage With Canadian Climate Considerations

Store at room temperature up to 25°C (77°F) and avoid freezing.

Protect the tube from excessive heat and direct sunlight and avoid leaving it in an unheated car in winter or a hot car in summer.

If a tube has frozen or been exposed to extreme heat, advise disposal and replacement to ensure product integrity.

Guidelines For Proper Use

What should Canadian prescribers and pharmacists cover during counselling?

Confirm indication, age and product strength and document the counselling conversation in the patient record.

Ask about allergy history and any known G6PD deficiency or prior methemoglobinemia.

Demonstrate pea‑sized application on clean, dry skin and advise to avoid eyes, mouth and other mucous membranes.

Set realistic expectations about onset of effect and plan a 12‑week review for treatment response.

Coordinate combination therapy with benzoyl peroxide or retinoids to minimise irritation and warn about possible staining with benzoyl peroxide.

Advise patients to seek urgent care for sudden shortness of breath, cyanosis, profound fatigue or dark urine and to contact the provincial poison centre for guidance if ingestion occurs.

Help patients check DIN listings and provincial coverage and discuss generic options when cost is a concern.

Delivery Across Canada (English)